CJC-1295 (no DAC)
Modified growth hormone releasing hormone analogue without drug affinity complex. Researched for pulsatile GH release patterns.
Subscribe & Save
Recurring orders launching soon
Calculate your dose
Free reconstitution calculator, preset for CJC-1295.
About CJC-1295 (no DAC)
Modified growth hormone releasing hormone analogue without drug affinity complex. Researched for pulsatile GH release patterns.
Disclaimer: This product is sold for research purposes only. It is not intended for human consumption, diagnosis, treatment, or prevention of any disease. Always consult with a qualified professional.
You may also like
Tirzepatide
Dual GIP and GLP-1 receptor agonist peptide. Widely researched for its role in metabolic regulation and body composition studies.
BPC-157
Body protection compound derived from gastric juice proteins. Extensively studied for tissue repair, gut healing, and recovery applications.
Retatrutide
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. A next-generation compound for metabolic research applications.
Ipamorelin
Selective growth hormone secretagogue peptide. Studied for targeted GH release without significant impact on cortisol or prolactin levels.